An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome

por Talreja, Vikas T., Noronha, Vanita, Joshi, Amit, Patil, Vijay, Prabhash, Kumar
Publicado 2020

Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience

por Talreja, Vikas T., Noronha, Vanita, Patil, Vijay M., Joshi, Amit, Prabhash, Kumar
Publicado 2020

An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma

por Talreja, Vikas T., Noronha, Vanita, Joshi, Amit, Patil, Vijay, Mahajan, Abhishek, Prabhash, Kumar
Publicado 2019

Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience

por Talreja, Vikas T., Noronha, Vanita, Joshi, Amit, Patil, Vijay, Mahajan, Abhishek, Prabhash, Kumar
Publicado 2019

Real-World Experience of Patients with Inoperable, Stage III Non-small-Cell Lung Cancer Treated with Durvalumab after Chemoradiotherapy: Indian Experience

por Noronha, Vanita, Talreja, Vikas T., Patil, Vijay, Joshi, Amit, Menon, Nandini, Mahajan, Abhishek, Janu, Amit, Prabhash, Kumar
Publicado 2020

Metronomic palliative chemotherapy in maxillary sinus tumor

por Patil, Vijay M., Noronh, Vanita, Joshi, Amit, Karpe, Ashay, Talreja, Vikas, Chandrasekharan, Arun, Dhumal, Sachin, Prabhash, Kumar
Publicado 2016

Palliative chemotherapy in carcinoma nasopharynx

por Patil, Vijay M., Joshi, Amit, Noronha, Vanita, Talreja, Vikas, Simha, Vijai, Dhumal, Sachin, Bandekar, Bhavesh, Chandrasekharan, Arun, Prabhash, Kumar
Publicado 2019

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer

por Noronha, Vanita, Pande, Nikhil, Joshi, Amit, Patil, Vijay, Trivedi, Vaishakhi, Chougule, Anuradha, Janu, Amit, Mahajan, Abhishek, Talreja, Vikas, Prabhash, Kumar
Publicado 2020

Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis

por Ostwal, Vikas, Sahu, Arvind, Ramaswamy, Anant, Sirohi, Bhawna, Bose, Subhadeep, Talreja, Vikas, Goel, Mahesh, Patkar, Shraddha, Desouza, Ashwin, Shrikhande, Shailesh V.
Publicado 2017

Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation

por Mandal, Tanmoy, Verma, Anuj, Talreja, Vikas, Parthiban, Sangeetha Kamrajpuram, Gokarn, Anant, Jain, Hasmukh, Bagal, Bhausaheb, Tandon, Sandeep, Sengar, Manju, Shet, Tanuja
Publicado 2018

Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non–High-Dose Methotrexate–Based, Dose-Dense Combination Chemotherapy, in a...

por Bajpai, Jyoti, Chandrasekharan, Arun, Simha, Vijai, Talreja, Vikas, Karpe, Ashay, Pandey, Nikihil, Singh, Ashish, Rekhi, Bharat, Vora, Tushar, Ghosh, Jaya, Banavali, Shripad, Gupta, Sudeep
Publicado 2018

Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients

por Patil, Vijay, Joshi, Amit, Noronha, Vanita, Bhattacharjee, Atanu, Dhumal, Sachin, Chandrakanth, M. V., Karpe, Ashay, Talreja, Vikas, Chandrasekharan, Arun, Turkar, Siddharth, Pande, Nikhil, Ramaswamy, Anant, Prabhash, Kumar
Publicado 2018

An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settings

por Kapoor, Akhil, Noronha, Vanita, Joshi, Amit, Patil, Vijay M, Menon, Nandini, Bollam, Rajesh, Talreja, Vikas, Goud, Supriya, More, Sucheta, Solanki, Leena, Shah, Srushti, Chougule, Anuradha, Mahajan, Abhishek, Prabhash, Kumar
Publicado 2021

Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach

por Patil, Vijay, Noronha, Vanita, Joshi, Amit, Deodhar, Jayita, Goswami, Savita, Chakraborty, Santam, Ramaswamy, Anant, Dhumal, Sachin, M.V., Chandrakanth, Karpe, Ashay, Pande, Nikhil, Talreja, Vikas, Chandrasekharan, Arun, Turkar, Siddharth, Prabhash, Kumar
Publicado 2018

Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy

por Noronha, Vanita, Patil, Vijay, Joshi, Amit, Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, More, Sucheta, Goud, Supriya, Karpe, Ashay, Ramaswamy, Anant, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2017

Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

por Joshi, Amit, Patil, Vijay, Noronha, Vanita, Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2018

Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

por Joshi, Amit, Noronha, Vanita, Patil, Vijay M., Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2017

A real‐world data of Immune checkpoint inhibitors in solid tumors from India

por Noronha, Vanita, Abraham, George, Patil, Vijay, Joshi, Amit, Menon, Nandini, Mahajan, Abhishek, Janu, Amit, Jain, Srushti, Talreja, Vikas T, Kapoor, Akhil, Kumar Singh, Gunjesh, Khaddar, Satvik, Gupta, Kushal, Rathinasamy, Narmadha, Srinivas, Sujay, Agrawal, Amit, Ventrapati, Pradeep, Prabhash, Kumar
Publicado 2021

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

por Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Choughule, Anuradha Bharat, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2017

Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation—a phase 3 study

por Joshi, Amit, Patil, Vijay Maruti, Noronha, Vanita, Bhattacharjee, Atanu, Menon, Nandini, Kumar, Amit, Jain, Parmanand, Mukadam, Sadaf, Shrinivas, Avadhoot, Punia, Anjali, Abhyankar, Anuja, Agarwal, Amit, Khaddar, Satvik, Rajpurohit, Anu, Kumar, Kanteti Aditya Pavan, Ravind, Rahul, Das, Kishore, Talreja, Vikas, Dhumal, Sachin, Prabhash, Kumar
Publicado 2021